Performance ingredientsPhysta® Tongkat Ali

Physta®, World’s best Tongkat Ali

The most
clinically researched
Tongkat Ali extract

Give your customers the Tongkat Ali with the most research behind it. Physta is shown in placebo-controlled human studies to raise testosterone, reduce fatigue, increase strength and lower cortisol, with research in immunity and menopause too.* Harvested in the Malaysian rainforest by Orang Asli communities, and sold in the Americas as LJ100®.

Request the specification Speak to sales
Harvesting Tongkat Ali root in the Malaysian rainforest
28human studies, all on Physta
20+years of research
400+products formulated with Physta
36countries

Formulating with Physta

New formulationsTestosterone and healthy ageingClinical evidence across six areas, in men and women Existing formulationsMove to the clinical standardReformulate with the extract behind the research SourcingTongkat Ali extract supplySpecifications, documentation and certifications
Clinical evidence

Six benefits, backed by 28 human studies

Testosterone, energy, strength, stress, immunity and menopause, in men and women. Every study was conducted on Physta, so the evidence applies to the ingredient in your formula.

Testosterone

12 studies
+37%testosterone vs placebo*

Also studied for libido and fertility.

200mg a day, 4 weeks

Menopause

5 studies
33.9%better menopause quality of life*

Covered by US patent 11,058,737.

100mg a day, 12 weeks

Stress

3 studies
−16%cortisol vs placebo*

Tension −11%, anger −12%.

200mg a day, 4 weeks

Strength and muscle

8 studies
+17%knee strength with training*

Against 14% with training and placebo. Men aged 40 to 59.

200mg a day, 6 months

Energy

8 studies
−42%fatigue score*

Men aged 50 to 70. −50% at 200mg. The placebo group did not change (p < .001).

100mg a day, 12 weeks

Immunity

2 studies
+5%overall immune cell score, with more T cells than placebo*

Calculated from the study data. Covered by US patent 11,166,998.

200mg a day, 4 weeks

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Studies can cover more than one area. Results are study outcomes, not claims for finished products.

The research, explained

Plain-language summaries of the human studies behind Physta.

Read the research on tongkatali.com

Scientific advisors

  • Dr Shawn Talbott
  • Dr Annie George
  • Dr Ralf Henkel
  • Chris Kilham
  • Prof Emeritus Dr Ismail Tambi
  • Dr Sun Tao
  • Prof Katsuiku Hirokawa
  • Dr Kamariah Long
  • Dr Abdul Rasip Abdul Ghani
  • Dr Jay Udani
  • Dr T. G. Sambandan
  • Prof Anthony J. Sinskey
  • Prof Chokyun Rha

Research collaborations and institutional partners

  • Massachusetts Institute of Technology
  • Tokyo Medical and Dental University
  • University of the Western Cape
  • University of Malaya
  • American Botanical Council
  • JAI Research Foundation
  • KGK Science
  • Charles River
  • Intertek
  • Eurofins
  • Bio-Me
  • Ortho Medico
  • SRE Service Co., Ltd.
Request study summaries Speak to sales
Quality standard

Six questions your supplier should answer

Eurycomanone is Tongkat Ali's principal active compound. The clinically researched dose for testosterone is 1.6mg a day, and extracts with similar labels can deliver very different amounts.

QuestionPhystaTypical extract
How much eurycomanone does it contain?0.8 to 1.5%, every batchOften unstated
Are its other active markers controlled?Yes, three moreRarely
Has it been studied in humans?Yes, in 28 human studiesVaries by supplier
Does it meet the Malaysian Standard?Yes, every batch2 of 22 tested by Biotropics met all four markers
Is the identity of the root verified?Yes, by HPTLC testingOften not
Can it be traced to its source?Yes, fully tracedRarely fully
Clinically researched dose

200mg of Physta a day delivers at least 1.6mg of eurycomanone, the clinically researched dose for testosterone.

Eurycomanone content, % of extract
Physta eurycomanone range Physta is standardised to between 0.8 and 1.5 percent eurycomanone. Extracts below 0.8 percent are under-standardised. Levels above 1.5 percent have not been clinically researched. Physta range Under-standardised Not clinically researched 0%0.5%1%2% 0.8%1.5%
  • Under 0.8%: under-standardised
  • 0.8 to 1.5%: Physta range
  • Over 1.5%: not clinically researched

Percentage × daily dose = milligrams of eurycomanone. At 200mg, 0.8% delivers 1.6mg and 1.5% delivers 3mg. A ratio such as 200:1 refers to the quantity of root used, not the strength of the extract. What extract ratios mean

Extract samples in the testing machine that checks every batch of Physta for eurycomanone
Sourcing and supply

Know exactly what goes into your product

Physta begins with Tongkat Ali root from Malaysia's biodiverse rainforests. Every batch is extracted, standardised and tested to the same specification.

  1. Sourced

    Harvested by Orang Asli communities.

  2. Authenticated

    Each incoming batch of root is HPTLC tested to confirm species and plant part.

  3. Extracted

    By a water extraction process co‑developed with MIT.

  4. Standardised

    To MS 2409:2011, the Malaysian Standard Physta helped develop.

  5. Tested and released

    Every batch is tested for heavy metals and microbes before release.

Mature Tongkat Ali trees Dried Tongkat Ali root, cut for extraction

Documentation and terms

  • Specification sheet, with all four markers and release limits
  • Certificate of analysis for every batch
  • Study summaries and claims guidance for your market
  • Regulatory documentation for your markets
  • Pricing, minimum order quantities and lead times, by volume
Enquire about pricing

Biotropics Malaysia Berhad is the leading global supplier of Tongkat Ali extract. For finished Tongkat Ali products under your own brand, see Manufacturing and white label. In the Americas, Physta is available as LJ100® through HP Ingredients.

Physta extract powder in a wooden bowl
Botanical name
Eurycoma longifolia, root
US status
Self‑affirmed GRAS since 2013
Certifications
Halal, Kosher, GMP, ISO 22000, HACCP. US FDA inspected.
Form
Water‑soluble powder, 3‑year shelf life
Patents
US 11,058,737: menopause. US 11,166,998: immunity. 42 active patents across Biotropics’ ingredients.
Formats
Capsules, tablets, gummies, powders, sachets, ready‑to‑drink, functional coffee
Ingredient of the Year, Healthy AgeingFunctional Foods for Wellness 2024
Ingredient of the Year finalist, BotanicalNutraIngredients Asia 2025
Ingredient of the Year finalist, Sports NutritionNutraIngredients Asia 2026
Existing formulations

Switch to Physta in five steps

Move your product onto the extract behind the research, with documentation and support at every step.

  1. Assess

    Review your current extract against the six supplier questions and the formulation check.

  2. Sample

    Trial Physta in your formula and format.

  3. Document

    Specification, certificates of analysis, study summaries and regulatory documents for your market, with claims review.

  4. Supply

    Volumes and lead times agreed with the Physta team.

  5. Launch

    Point your customers to tongkatali.com for the research behind Tongkat Ali.

Request a sample Speak to sales

Formulation check

A typical 200:1 label is filled in.

:1
Eurycomanone a day

  • Daily dose

  • Eurycomanone

  • Standardisation

  • Extraction

Physta at 200mg a day: at least 1.6mg eurycomanone, tested by HPLC in every batch. A water extract of root, standardised to MS 2409:2011 and tested in 28 human studies.

Compare with the Physta specification
Specification and sales

Request the spec sheet

I'm interested in

Speak to the Physta team

Performance Ingredients Team

Email marketing@biotropicsmalaysia.com
The Americas Available as LJ100® through HP Ingredients.
Office Lot 21, Jalan U1/19, Hicom‑Glenmarie Industrial Park, 40150 Shah Alam, Selangor, Malaysia